(Q41722012)

8 October 2017

1 reference

title

Management of adult T-cell leukaemia/lymphoma (English)

1 reference

8 October 2017

1 reference

Pawson R

1

1 reference

8 October 2017

Mufti GJ

series ordinal

2

1 reference

8 October 2017

Pagliuca A

series ordinal

3

1 reference

8 October 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

British Journal of Haematology

8 October 2017

published in

1 reference

8 October 2017

volume

100

1 reference

8 October 2017

issue

3

1 reference

8 October 2017

page(s)

453-458

1 reference

Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia/lymphoma patients.

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Successful treatment of HTLV-1-associated acute adult T-cell leukaemia lymphoma by allogeneic bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

BEAM regimen and G-CSF in HTLV-I-associated T-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Human T cell leukaemia/lymphoma virus and blood donation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

An HTLV-I/II vaccine: from animal models to clinical trials?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

HTLV screening of Swedish blood donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

The human interleukin-2 receptor: normal and abnormal expression in T cells and in leukemias induced by the human T-lymphotropic retroviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Clinical, morphological and virological features of an HTLV-I-positive case of ATL in a white man from the Caucasus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Adult T-cell leukemia/lymphoma in Jamaica: 1986-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Effective treatment of adult T cell leukemia/lymphoma with a novel oral antitumor agent, MST-16

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus Epidemiology Donor Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Vertical transmission of adult T-cell leukaemia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Infection of donor lymphocytes with human T lymphotrophic virus type 1 (HTLV-I) following allogeneic bone marrow transplantation for HTLV-I positive adult T-cell leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

2'-Deoxycoformycin therapy in adult T-cell leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

HTLV-I is endemic in southern Italy: detection of the first infectious cluster in a white population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Mature T-Cell Leukemias and Leukemia/Lymphoma Syndromes: Review of Our Experience in 175 Cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Transmission of human T-lymphotrophic virus type 1 by bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Treatment of adult T-cell leukemia/lymphoma with MST-16, a new oral antitumor drug and a derivative of bis(2,6-dioxopiperazine). The MST-16 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

A Retrospective Study on Transmission of Adult T Cell Leukemia Virus by Blood Transfusion: Seroconversion in Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Blood transfusion and HTLV-I associated myelopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Hyperinfection with strongyloides after treatment for adult T cell leukaemia-lymphoma in an African immigrant

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

HTLV-I screening in Britain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Adult T-cell leukemia/lymphoma in London: clinical experience of 21 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

T-cell malignancies in Brazil. Clinico-pathological and molecular studies of HTLV-I-positive and -negative cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Detection of the human T cell lymphoma virus p19 in cells of some patients with cutaneous T cell lymphoma and leukemia using a monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Lymphomatous presentation of CD4+/CD8+ HTLV-1-related adult T-cell leukemia/lymphoma in an Iranian woman.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Adult T-cell leukaemia/lymphoma with multiple integrations of human T-cell lymphotropic virus type I proviral DNA: differing clinical features are linked to varied proviral integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Recombinant interferon beta and gamma in the treatment of adult T-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Treatment of adult T-cell leukaemia-lymphoma with irinotecan hydrochloride (CPT-11). CPT-11 Study Group on Hematological Malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Characteristics of chemotherapy-induced clinical remission in long survivors with aggressive adult T-cell leukemia/lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Combination chemotherapy (RCM protocol: response-oriented cyclic multidrug protocol) for the acute or lymphoma type adult T-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Efficacy of selected versus random blood donor screening for anti-HTLV-I antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

The promiscuous IL-2/IL-15 receptor: a target for immunotherapy of HTLV-I-associated disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

HTLV-1-associated cutaneous disease: a clinicopathological and molecular study of patients from the U.K.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Human T-lymphotropic virus type I in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Clinical consequences of 2'-deoxycoformycin treatment in patients with refractory adult T-cell leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Treatment of Adult T-Cell Leukemia-Lymphoma with Zidovudine and Interferon Alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

Autopsy Findings in 47 Cases of Adult T-cell Leukemia/Lymphoma in Miyazaki Prefecture, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00582.X

10.1046/J.1365-2141.1998.00582.X

21 January 2018

Identifiers

DOI

1 reference

8 October 2017

1 reference